Displaying drugs 2301 - 2325 of 2797 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Seladelpar | 444.47 C21H23F3O5S |  | A PPAR-delta agonist used to treat primary biliary cholangitis alone or in combination with ursodeoxycholic acid in adults. | Hypolipidemic Agents / PPAR delta, agonists |
| Selegiline | 187.286 C13H17N |  | A monoamine oxidase inhibitor used to treat major depressive disorder and Parkinson's. | Agents that produce hypertension / Agents that reduce seizure threshold / Anti-Parkinson Drugs |
| Selenic acid | 144.97 H2O4Se |  | An ingredient found in a variety of supplements and vitamins. | Selenium Compounds |
| Selenious acid | 128.97 H2O3Se |  | An ingredient found in supplements, vitamins, parenteral nutrition, and dandruff shampoo. | Electrolyte Solutions / Selenium Compounds |
| Selenium | 78.96 Se |  | An ingredient found in a variety of supplements and vitamins. | Antioxidants / Chalcogens / Minerals / Selenium Compounds / Trace Elements |
| Selenium Sulfide | 143.09 S2Se |  | An antifungal used to treat dandruff, seborrheic dermatitis of the scalp, and tinea capitis. | Antifungals for Dermatological Use / Antifungals for Topical Use / Dermatologicals / Selenium Compounds |
| Selenomethionine | 196.11 C5H11NO2Se |  | Selenomethionine is a naturally occuring amino acid in some plant materials such as cereal grains, soybeans and enriched yeast but it cannot be synthesized from animals or humans. It can... | Organoselenium Compounds |
| Selenomethionine Se-75 | 192.071 C5H11NO2Se |  | Not Annotated | Organoselenium Compounds |
| Selexipag | 496.63 C26H32N4O4S |  | A non prostanoid IP prostacyclin receptor agonist used to treat pulmonary arterial hypertension. | Platelet Aggregation Inhibitors Excl. Heparin |
| Selinexor | 443.313 C17H11F6N7O |  | Selinexor is indicated in combination with bortezomib and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. Selinexor is also indicated... | Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Nuclear Export Inhibitors / OATP1B3 inhibitors |
| Selpercatinib | 525.613 C29H31N7O3 |  | A RET receptor tyrosine kinase inhibitor for the treatment of RET-driven non-small cell lung cancer, medullary thyroid cancer, and thyroid cancer in appropriate patient populations. | Kinase Inhibitor |
| Selumetinib | 457.68 C17H15BrClFN4O3 |  | A MEK 1/2 inhibitor used in pediatric patients to treat neurofibromatosis type 1 (NF1) accompanied by symptomatic, inoperable plexiform neurofibromas (PN). | Mitogen-activated protein kinase (MEK) inhibitors |
| Semaglutide | 4113.641 C187H291N45O59 |  | A glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults. | Glucagon-like peptide-1 (GLP-1) analogues |
| Serdexmethylphenidate | 499.52 C25H29N3O8 |  | A prodrug of the CNS stimulant dexmethylphenidate used as a first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD). | Centrally Acting Sympathomimetics |
| Sertaconazole | 437.77 C20H15Cl3N2OS |  | A topical antifungal agent used in the treatment of interdigital tinea pedis in immunocompetent patients. | Imidazole and Triazole Derivatives / Imidazole Derivatives |
| Sertindole | 440.941 C24H26ClFN4O |  | An atypical antipsychotic indicated in the treatment of schizophrenia. | Indole Derivatives |
| Sertraline | 306.23 C17H17Cl2N |  | A selective serotonin reuptake inhibitor (SSRI) indicated to treat major depressive disorder, social anxiety disorder and many other psychiatric conditions. | Antidepressive Agents Indicated for Depression / Drugs causing inadvertant photosensitivity / Selective Serotonin Reuptake Inhibitors / Serotonin Modulators |
| Setmelanotide | 1117.32 C49H68N18O9S2 |  | A drug indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome. | Centrally Acting Antiobesity Products |
| Sevelamer | 149.619 C6H12ClNO |  | A phosphate binder used to treat hyperphosphatemia. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia |
| Sevoflurane | 200.0548 C4H3F7O |  | A inhalation anaesthetic agent used for induction and maintenance of general anesthesia during surgical procedures. | Hydrocarbons, Halogenated |
| Sibutramine | 279.848 C17H26ClN |  | A norepinephrine, serotonin and dopamine reuptake inhibitor indicated to assist with weight loss in obesity. | Centrally Acting Antiobesity Products |
| Silanol | 48.116 H4OSi |  | Silanol is an FDA-approved food contact substance that is commonly used in organosilicon chemistry and silicate mineralogy. | Silicon Compounds |
| Sildenafil | 474.576 C22H30N6O4S |  | A phosphodiesterase inhibitor used for the treatment of erectile dysfunction. | Drugs Used in Erectile Dysfunction / Sulfonamides |
| Silicon | 28.085 Si |  | A micronutrient indicated in nutritional products to treat or prevent silicon deficiencies. | Metalloids / Trace Elements |
| Silicon dioxide | 60.0843 O2Si |  | An ingredient found in a variety of supplements and vitamins. | Hygroscopic Agents / Minerals / Oxides / Silicon Compounds |
Displaying drugs 2301 - 2325 of 2797 in total